EEDQ
Sign in to saveAlso known as 2-ethoxy-1-ethoxycarbonyl-1,2-dihydroquinoline, N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline
'''N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ''') is a dopamine-receptor antagonist.
Research
411 papers- Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).Proceedings of the National Academy of Sciences of the United States of America · 1997
- N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ): a new tool to probe CNS receptor function.Advances in experimental medicine and biology · 1988
- Effects of EEDQ on the synthesis and metabolism of dopamine in preweanling and adult rats.Neuropharmacology · 1994
- EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.European journal of pharmacology · 1988
- Ontogenetic effects of EEDQ on amphetamine-induced behaviors of rats: role of presynaptic processes.Psychopharmacology · 1994
via PubMed
~1 min read
Encyclopedic overview
1 sectionsContents
- References
'''N-Ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ') is a dopamine-receptor antagonist.
EEDQ is also a highly specific reagent for carboxyl groups. It enables the coupling of acylamino acids with amino acid esters in high yield and without racemization.
Excerpted from Wikipedia’s “EEDQ” article, available under the CC BY-SA 4.0 licence.